ResearcherUniversity of TurinActive in the last 2 years
Miriam Martini
Matched on ORCID iD 0000-0002-4262-946X; OpenAlex author ID A5075168526. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 26
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 9
- Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. Last author DOI 10.1016/j.tem.2026.03.004↗
- Metabolic plasticity in pancreatic cancer: The mitochondrial connection. Last author DOI 10.1016/j.molmet.2024.102089↗
- The molecular logic of early metastasis in pancreatic cancer: crosstalk between tumor and microenvironment. Last author DOI 10.3389/fcell.2025.1726581↗
- Exploiting pancreatic cancer metabolism: challenges and opportunities. Last author DOI 10.1016/j.molmed.2024.03.008↗
- Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer. Last author DOI 10.1136/gutjnl-2021-325117↗
- Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2022.103749↗
- Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis. Last author DOI 10.1053/j.gastro.2021.12.242↗
- Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward. Co-author DOI 10.1053/j.gastro.2021.06.080↗
- The role of metabolic adaptation to nutrient stress in pancreatic cancer. Last author DOI 10.15698/cst2018.12.166↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrea Costamagna · 5 shared papers, 2022–2026 · strength 1.38
- Paper The molecular logic of early metastasis in pancreatic cancer: crosstalk between tumor and microenvironment. DOI 10.3389/fcell.2025.1726581↗
- Paper Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. DOI 10.1016/j.tem.2026.03.004↗
- Paper Metabolic plasticity in pancreatic cancer: The mitochondrial connection. DOI 10.1016/j.molmet.2024.102089↗
- Maria Chiara De Santis · 4 shared papers, 2018–2026 · strength 0.90
- Paper Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. DOI 10.1016/j.tem.2026.03.004↗
- Paper Exploiting pancreatic cancer metabolism: challenges and opportunities. DOI 10.1016/j.molmed.2024.03.008↗
- Paper Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer. DOI 10.1136/gutjnl-2021-325117↗
- Ghiglione Noemi · 2 shared papers, 2025 · strength 0.73
- Paola Cappello · 4 shared papers, 2021–2024 · strength 0.65
- Paper Exploiting pancreatic cancer metabolism: challenges and opportunities. DOI 10.1016/j.molmed.2024.03.008↗
- Paper Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreat… DOI 10.1053/j.gastro.2021.12.242↗
- Paper Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer. DOI 10.1136/gutjnl-2021-325117↗
- Elisa Giovannetti · 4 shared papers, 2021–2023 · strength 0.57
- Paper Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer. DOI 10.1016/j.critrevonc.2022.103749↗
- Paper Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreat… DOI 10.1053/j.gastro.2021.12.242↗
- Paper Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer. DOI 10.1136/gutjnl-2021-325117↗
- Paolo Ettore Porporato · 2 shared papers, 2023–2025 · strength 0.43
- Alessandro Carrer · 1 shared paper, 2026 · strength 0.39
- Bruno Bockorny · 1 shared paper, 2024 · strength 0.28
- Francesco Novelli · 2 shared papers, 2022–2023 · strength 0.27
- Vincenzo Corbo · 2 shared papers, 2021–2023 · strength 0.23
- Aldo Scarpa · 2 shared papers, 2021–2023 · strength 0.23
- Motahareh Mortazavi · 1 shared paper, 2022 · strength 0.20
- Fatemeh Moosavi · 1 shared paper, 2022 · strength 0.20
- Omidreza Firuzi · 1 shared paper, 2022 · strength 0.20
- Pietro Delfino · 1 shared paper, 2023 · strength 0.13
- Abhishek Derle · 1 shared paper, 2018 · strength 0.11
- Jay Campbell · 1 shared paper, 2021 · strength 0.10
- Antonio Pea · 1 shared paper, 2021 · strength 0.10
- Raffaella Casolino · 1 shared paper, 2021 · strength 0.10
- Geny Piro · 1 shared paper, 2021 · strength 0.10
- Michèle Milella · 1 shared paper, 2021 · strength 0.10
- Claudio Bassi · 1 shared paper, 2021 · strength 0.10
- Chiara Braconi · 1 shared paper, 2021 · strength 0.10
- Carmine Carbone · 1 shared paper, 2021 · strength 0.10
- David Kuang-Fu Chang · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.